Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates

Mammalian paraoxonase-1 hydrolyses a very broad spectrum of esters such as certain drugs and xenobiotics. The aim of this study was to determine whether carbamates influence the activity of recombinant PON1 (rePON1). Carbamates were selected having a variety of applications: bambuterol and physostig...

Full description

Bibliographic Details
Main Authors: Anita Bosak, Aljoša Bavec, Tilen Konte, Goran Šinko, Zrinka Kovarik, Marko Goličnik
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/1/211
_version_ 1818850647889412096
author Anita Bosak
Aljoša Bavec
Tilen Konte
Goran Šinko
Zrinka Kovarik
Marko Goličnik
author_facet Anita Bosak
Aljoša Bavec
Tilen Konte
Goran Šinko
Zrinka Kovarik
Marko Goličnik
author_sort Anita Bosak
collection DOAJ
description Mammalian paraoxonase-1 hydrolyses a very broad spectrum of esters such as certain drugs and xenobiotics. The aim of this study was to determine whether carbamates influence the activity of recombinant PON1 (rePON1). Carbamates were selected having a variety of applications: bambuterol and physostigmine are drugs, carbofuran is used as a pesticide, while Ro 02-0683 is diagnostic reagent. All the selected carbamates reduced the arylesterase activity of rePON1 towards the substrate <i>S</i>-phenyl thioacetate (PTA). Inhibition dissociation constants (<i>K</i><sub>i</sub>), evaluated by both discontinuous and continuous inhibition measurements (progress curves), were similar and in the mM range. The rePON1 displayed almost the same values of <i>K</i><sub>i</sub> constants for Ro 02-0683 and physostigmine while, for carbofuran and bambuterol, the values were approximately ten times lower and two times higher, respectively. The affinity of rePON1 towards the tested carbamates was about 3&#8722;40 times lower than that of PTA. Molecular modelling of rePON1-carbamate complexes suggested non-covalent interactions with residues of the rePON1 active site that could lead to competitive inhibition of its arylesterase activity. In conclusion, carbamates can reduce the level of PON1 activity, which should be kept in mind, especially in medical conditions characterized by reduced PON1 levels.
first_indexed 2024-12-19T06:52:28Z
format Article
id doaj.art-8716715bc3754e49ba7768b56e7d6ee6
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-19T06:52:28Z
publishDate 2020-01-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-8716715bc3754e49ba7768b56e7d6ee62022-12-21T20:31:41ZengMDPI AGMolecules1420-30492020-01-0125121110.3390/molecules25010211molecules25010211Interactions of Paraoxonase-1 with Pharmacologically Relevant CarbamatesAnita Bosak0Aljoša Bavec1Tilen Konte2Goran Šinko3Zrinka Kovarik4Marko Goličnik5Institute for Medical Research and Occupational Health, HR 10000 Zagreb, CroatiaInstitute of Biochemistry, Faculty of Medicine, University of Ljubljana, SI 1000 Ljubljana, SloveniaInstitute of Biochemistry, Faculty of Medicine, University of Ljubljana, SI 1000 Ljubljana, SloveniaInstitute for Medical Research and Occupational Health, HR 10000 Zagreb, CroatiaInstitute for Medical Research and Occupational Health, HR 10000 Zagreb, CroatiaInstitute of Biochemistry, Faculty of Medicine, University of Ljubljana, SI 1000 Ljubljana, SloveniaMammalian paraoxonase-1 hydrolyses a very broad spectrum of esters such as certain drugs and xenobiotics. The aim of this study was to determine whether carbamates influence the activity of recombinant PON1 (rePON1). Carbamates were selected having a variety of applications: bambuterol and physostigmine are drugs, carbofuran is used as a pesticide, while Ro 02-0683 is diagnostic reagent. All the selected carbamates reduced the arylesterase activity of rePON1 towards the substrate <i>S</i>-phenyl thioacetate (PTA). Inhibition dissociation constants (<i>K</i><sub>i</sub>), evaluated by both discontinuous and continuous inhibition measurements (progress curves), were similar and in the mM range. The rePON1 displayed almost the same values of <i>K</i><sub>i</sub> constants for Ro 02-0683 and physostigmine while, for carbofuran and bambuterol, the values were approximately ten times lower and two times higher, respectively. The affinity of rePON1 towards the tested carbamates was about 3&#8722;40 times lower than that of PTA. Molecular modelling of rePON1-carbamate complexes suggested non-covalent interactions with residues of the rePON1 active site that could lead to competitive inhibition of its arylesterase activity. In conclusion, carbamates can reduce the level of PON1 activity, which should be kept in mind, especially in medical conditions characterized by reduced PON1 levels.https://www.mdpi.com/1420-3049/25/1/211paraoxonase-1arylesterase activityphenyl acetate<i>s</i>-phenyl thioacetate<i>p</i>-nitrophenyl acetatecarbamatesreversible inhibition
spellingShingle Anita Bosak
Aljoša Bavec
Tilen Konte
Goran Šinko
Zrinka Kovarik
Marko Goličnik
Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
Molecules
paraoxonase-1
arylesterase activity
phenyl acetate
<i>s</i>-phenyl thioacetate
<i>p</i>-nitrophenyl acetate
carbamates
reversible inhibition
title Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
title_full Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
title_fullStr Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
title_full_unstemmed Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
title_short Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
title_sort interactions of paraoxonase 1 with pharmacologically relevant carbamates
topic paraoxonase-1
arylesterase activity
phenyl acetate
<i>s</i>-phenyl thioacetate
<i>p</i>-nitrophenyl acetate
carbamates
reversible inhibition
url https://www.mdpi.com/1420-3049/25/1/211
work_keys_str_mv AT anitabosak interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates
AT aljosabavec interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates
AT tilenkonte interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates
AT goransinko interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates
AT zrinkakovarik interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates
AT markogolicnik interactionsofparaoxonase1withpharmacologicallyrelevantcarbamates